TWO · 6748.TWO
ACRO Biomedical Co., Ltd.
NT$182.50-NT$11.50 (-5.93%)
ACRO Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.13% below the high.
Loading market information…
TAI · 6796.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Medimaging Integrated Solution Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.94% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Medimaging Integrated Solution Inc.’s forward annual dividend is NT$0.25 per share, paid annual. The forward yield is 0.49% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Medimaging Integrated Solution Inc.’s next earnings report is currently expected on Nov 6, 2026, with estimated earnings per share of NT$0.61. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Medimaging Integrated Solution Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Medimaging Integrated Solution Inc. specializes in delivering advanced digital and mobile diagnostic technology. The company engineers and produces a variety of digital handheld diagnostic scopes, alongside their essential auxiliary equipment. A key product line is the Horus scope system, which encompasses optical coherence tomography (OCT) capabilities, integrated control units, specialized software, and a full suite of accessories. Beyond hardware, Medimaging leverages artificial intelligence for screening applications, notably in detecting diabetic retinopathy, managing wound care, and supporting general medical diagnosis. They also provide comprehensive endoscopy solutions, utilizing advanced micro camera modules to ensure superior visualization and facilitate patient-focused care. These high-performance micro camera modules are also available as standalone components. Established in 2010, Medimaging Integrated Solution Inc. maintains its headquarters in Hsinchu City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| May 10, 2024 |
| -NT$0.27-145.08% vs estimate |
| NT$97.10M-38.15% vs estimate |
| Q4 2023 | Mar 13, 2024 | NT$0.43 | NT$150.11M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$182.50-NT$11.50 (-5.93%)
ACRO Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.13% below the high.
NT$17.90-NT$0.10 (-0.56%)
TWi Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
NT$76.80+NT$0.30 (+0.39%)
SYN-TECH Chem. & Pharm. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
NT$45.75+NT$0.55 (+1.22%)
Sagittarius Life Science Corp’s quoted price sits in the lower half of its reported 52-week range, 31.72% below the high.
NT$60.40-NT$2.10 (-3.36%)
Shine-On BioMedical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.05% below the high.
NT$18.75-NT$0.10 (-0.53%)
ShareHope Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.63% below the high.
NT$73.00-NT$1.10 (-1.48%)
A Plus Biotechnology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 20.65% below the high.
NT$83.40-NT$2.40 (-2.8%)
Syngen Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.85% below the high.
